Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: General Internal Medicine Physicians (Europe)(?)

Council Members in this Study Group: 67

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Jupiter Study: impact on Rosuvastatin | 11-13-2008
Author: GLG Expert Contributor

Jupiter study demonstrated significant reduction of cardiovascular morbidity and mortality in patients with high hs-CRP and acceptable lipid profile. This study demonstrates that rosuvastatin might play a major role in modulating inflammation pathways predisposing to cardiovascular diseases....

What do the results presented by SIRTRIS at the 6th Annual Metabolic Diseases Drug Discovery and Development World Summit mean for SIRTRIS? | 07-25-2007
Author: GLG Expert Contributor

SIRTRIS is one of the leading "sites" worldwide on this field. They have profound knowledge about the human sirtuin gene family.

Yes, ALT-2074 might be a practical add-on to standard diabetes-2 treatments. But there is a way to go. | 07-05-2007
Author: GLG Expert Contributor

The article is important because it informs about the start of a phase-2 clinical trial in diabetics with CVD which uses a therapeutic principle, which is distinct from the standard diabets type two drugs, i. e. the compound ALT-2074 addresses free radical formation. Moreover, the trial is "genotype-guided"....

Without adequate vitamin D levels calcium cannot act properly | 11-22-2006
Author: GLG Expert Contributor

Calcium must always be seen in conjunction with an individiual's vitamin D -and magnesium status.

The niacin-priciple is per se good. Improvements regarding flushing are wellcome. | 11-22-2006
Author: GLG Expert Contributor

"There was no difference in lipid response when MK-0524 with ERN was compared to treatment with ERN alone." However.......

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Government/Military Hospital or Clinic
  • Academic Institution*

Most Common Job Types:

  • Physician - Attending Physician
  • Owner
  • Professor
  • Physician - Division Head
  • Physician - Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-05T05:45:18.353